IDEAYA Biosciences (IDYA) Enterprise Value (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Enterprise Value of -$671.2 million for Q1 2026, up 35.58% on a YoY basis from -$495.1 million in Q1 2025, and down 4.98% sequentially from -$639.4 million in Q4 2025.
IDEAYA Biosciences (IDYA) Enterprise Value (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of Enterprise Value data on file, last reported at -$671.2 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 35.58% year-over-year to -$671.2 million; the trailing twelve-month figure through Mar 2026 stood at -$671.2 million (up 35.58% YoY), and the FY2025 full-year result was -$639.4 million, up 5.46% from the prior year.
- Enterprise Value retreated to -$671.2 million in Q1 2026, from -$639.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$252.6 million in Q1 2022 to a low of -$1.0 billion in Q1 2025.
- A 5-year average of -$582.7 million and a median of -$639.4 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 105.84% in 2024 and jumped 35.58% in 2026, its largest moves.
- Tracing IDYA's Enterprise Value over 5 years: stood at -$364.8 million in 2022, then sank by 43.93% to -$525.1 million in 2023, then dropped by 28.79% to -$676.3 million in 2024, then advanced by 5.46% to -$639.4 million in 2025, then retreated by 4.98% to -$671.2 million in 2026.
- Business Quant data shows IDYA's Enterprise Value at -$671.2 million in Q1 2026, -$639.4 million in Q4 2025, and -$786.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | -671.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -671.20 Mn |
| Dec 31, 2025 | -639.39 Mn |
| Sep 30, 2025 | -786.89 Mn |
| Jun 30, 2025 | -669.74 Mn |
| Mar 31, 2025 | -1.04 Bn |
| Dec 31, 2024 | -676.32 Mn |
| Sep 30, 2024 | -920.03 Mn |
| Jun 30, 2024 | -701.66 Mn |
| Mar 31, 2024 | -698.77 Mn |
| Dec 31, 2023 | -525.11 Mn |
| Sep 30, 2023 | -468.75 Mn |
| Jun 30, 2023 | -493.72 Mn |
| Mar 31, 2023 | -339.47 Mn |
| Dec 31, 2022 | -364.83 Mn |
| Sep 30, 2022 | -386.24 Mn |
| Jun 30, 2022 | -268.62 Mn |
| Mar 31, 2022 | -252.60 Mn |
| Dec 31, 2021 | -246.77 Mn |
| Sep 30, 2021 | -264.55 Mn |
| Jun 30, 2021 | -274.18 Mn |